Skip to content

EleVation™ EVREFURB

by Bard Peripheral Vascular

EleVation EVREFURB is a mammographic stereotactic biopsy system (FDA Class II; FDA product code KNW, Instrument, Biopsy) made by Bard Peripheral Vascular, listed in FDA GUDID since 18 Jun 2020 (UDI-DI 00801741182464), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00801741182464 UDI-DI Date18 Jun 2020ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
EleVation™ Breast Biopsy System Driver Refurbished
MRI safety
MR Unsafe
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
EleVation™
Generic name
Mammographic stereotactic biopsy system
Model / Ref / Catalog
EVREFURB
Primary DI / UDI-DI
00801741182464
FDA product code
KNW
GMDN term
Mammographic stereotactic biopsy system
Device class
Class II
Regulation number
876.1075
GUDID distribution status
In Commercial Distribution
MRI safety
MR Unsafe

Similar devices in this category

Other devices filed under Mammographic stereotactic biopsy system.

Other devices from Bard Peripheral Vascular

See all devices from Bard Peripheral Vascular →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)